Moderna Shares (Diluted) increased by 39400.0% to 395M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.3%, from 386M to 395M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.
The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...
Standard metric for all public companies; essential for understanding the impact of equity-based compensation.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 431M | 434M | 426M | 419M | 412M | 405M | 381M | 381M | 382M | 384M | 399M | 1M | 386M | 388M | 390M | 1M | 395M |
| QoQ Change | — | +0.7% | -1.8% | -1.6% | -1.7% | -1.7% | -5.9% | +0.0% | +0.3% | +0.5% | +3.9% | -99.7% | >999% | +0.5% | +0.5% | -99.7% | >999% |
| YoY Change | — | — | — | -2.8% | -5.1% | -4.9% | -9.1% | -7.5% | -5.7% | +0.8% | +4.7% | — | +1.0% | +1.0% | -2.3% | +0.0% | +2.3% |